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هل الوقاية باهلالوبرييدول حتد من اهلذيان احلادث بعد التخدير بالكيتامني 
يف األطفال؟
م�شطفى عمرو، طارق �شم�ض، حامد الودعانى
امللخ�ص: الهدف: الكيتامني هو عقار خمدر ل ينتمى اىل جمموعة الباربيتيوريت ويتميز ببداية مفعول �رسيعة تدفع اىل التخدير العميق. 
الهالوبرييدول  الدرا�شة اىل تقييم فعالية عقار  الهذيان. تهدف هذه  ا�شتخدامه ب�شبب اخلوف من ظهور  الطوارئ عن  اأطباء  يحجم بع�ض 
والبكاء،   ، للهياج  ظهور  باأي  املتعلقة  الالحقة  البيانات  ت�شجيل  مت  الدرا�صة:  اجلراحية.  العمليات  بعد  الكيتامني  هذيان  من  الوقاية  يف 
املرتددين  املر�شي  كل  يف  الأعرا�ض  هذه  على  لل�شيطرة  الكيتامني  عقار  اإعطاء  بعد  والهذيان  الدراك  تغري  و  والأحالم،  الهالو�ض،  و 
537 مري�شا.  النتائج حلواىل  النتائج: �شجلت   2011 2010 اىل مايو  الفرتة من يونيو  على م�شت�شفى املن�شورة اجلامعى- م�رس فى 
تلقى، 267 )%49.7( الهالوبرييدول الوقائي قبل ا�شتخدام الكيتامني )جمموعة 1( بينما كان هناك 270 )%50.3( مل يتلقوا عقار 
التخدير. اظهرت جمموعة  2(. ظهر فرق كبري ذو دللة اح�شائية بني املجموعتني فى �شلوك املر�شى ما بعد  الهالوبرييدول ) جمموعة 
الهالوبرييدول- الكتامني مزيد من النعا �ض والهدوء )P ≤0.01( بينما قل التوتر )P ≤0.01( وال�شياح )P ≤0.01( واختالل التوجه ) 
التوهان( )P ≤0.01(. اخلال�صة: اأظهرت الدرا�شة اأن اإعطاء الهالوبرييدول قبل العمليات اجلراحية الب�شيطة من �شاأنه اأن يقلل اإىل حد كبري 
من حدوث الهذيان بعدها يف عينة من الأطفال امل�رسيني وهذا يتوافق مع العمل ال�شابق الذي اأجري يف البالغني. يحمل هذا العمل الكثري 
من المل يف احلد و الوقاية من الهذيان لكل اأنواع املر�شى من الأطفال اخلا�شعني للتخدير بعقار الكيتامني. 
مفتاح الكلمات: الكيتامني؛ التخدير؛ الطفال؛ الهذيان؛ الهالوبريدول.
abstract: Objectives: Ketamine is a non-barbiturate agent with rapid action onset that induces profound seda-
tion; however, some emergency physicians tend not to use ketamine because of the risk of emergence delirium (ED). 
This study aimed to evaluate the effectiveness of haloperidol prophylaxis in postoperative ketamine delirium in 
children. Methods: Prospective data relating to any emergence dreams, delirium, hallucinations, agitation, crying, 
altered perceptions, and necessary interventions were recorded in consecutive cases of ketamine delirium in patients 
attending Mansoura University Hospital, Egypt, from June 2010 to May 2011. Results: A total of 537 records were 
available for analysis. Of those, 267 received prophylactic haloperidol (49.7%). There were significant differences 
between the two groups regarding post-anaesthetic care unit behaviour. The ketamine-haloperidol groups included 
more patients who were sleepy, calm (P ≤0.01) and less irritable (P ≤0.01), with a lower incidence of crying (P ≤0.01) 
and disorientation (P ≤0.01). Conclusion: We found that preoperative administration of haloperidol decreases the 
incidence of postoperative delirium in a sample of Egyptian children undergoing minor surgery. This is congruent 
with earlier work conducted in adults. This work carries great hope to decrease and even prevent ED in hospitalised, 
non-surgical patients.
Keywords: Ketamine; Anesthesia; Children; Delirium; Haloperidol; Egypt.
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Advances in Knowledge
- This study is unique in investigating the use of prophylactic haloperidol in children to reduce postoperative ketamine delirium in our 
region. 
- The results of this study revealed that the preoperative administration of haloperidol will reduce the incidence of postoperative delirium 
in children undergoing minor surgery.
Applications to Patient Care
- This study throws light on the possibility of haloperidol use in hospitalised patients to decrease or even prevent delirium.
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Ketamine is a non-barbiturate agent with a rapid onset of action that induces profound analgaesia, sedation, 
and amnesia, with a short duration of action 
(15–30 minutes) and hence is associated with 
rapid recovery.1,2 Ketamine appears to have both 
central nervous system action and local anaesthetic 
properties. The main effects of this drug are 
mediated by the noncompetitive antagonism of 
the N-methyl-D-aspartate (NMDA) receptor in 
addition to binding to the muscarinic and opioid 
receptors.3 
The main advantage of ketamine over other 
categories of sedatives lies in maintaining airway 
reflexes with minimal cardiovascular and respiratory 
side effects.4 Ketamine-induced emergence delirium 
(ED) is characterised by restlessness, agitation, 
and combativeness, and a non-cognisant state in 
relation to the patient’s surroundings. Transient 
physical restraint may be the only way to deal with 
the patients’ disorientation.5,6 Anaesthesiologists 
attempt to prevent patients from having such adverse 
effects by the co-administration of short acting 
benzodiazepine (midazolam). Early anaesthetic 
literature supports this practice.7,8 The rate of 
emergence agitation with midazolam displayed 
no change when comparing ketamine alone to a 
combination of ketamine and midazolam.9,10
Haloperidol is another psychotropic medication 
that has been commonly used for the treatment 
of elderly and adult delirium.11 Haloperidol 
prophylaxis has been a matter of debate in the last 
two decades. Schrader et al. used haloperidol with 
a dose of 0.5 mg three times daily in the elderly, 
resulting in a reduction of delirium duration (from a 
mean of 11.8 to 5.4 days) and length of hospital stay 
in affected participants (from a mean of 22.6 to 17.1 
days).12 However, Atlas and Milles used haloperidol 
for the treatment of adult ketamine-induced ED in 
a single dose of 5 mg, administered intravenously 
(IV) to control delirium following maxillofacial 
surgery.13 Delirium among children and adolescents 
was managed well by haloperidol.14 In children with 
psychomotor agitation that was acutely threatening 
to their health status, IV haloperidol (at a loading 
dosage of 0.15–0.25 mg) was used over a period of 
30–45 minutes, followed by a maintenance dose of 
0.05–0.5 mg/Kg/24 hour.15–17 Critically ill children 
reportedly tolerate doses up to 1–1.5 mg/Kg/day 
(maximum 230 mg).18–20 
The pharmacological half-life of haloperidol 
is significantly longer than that of ketamine. 
Specifically, haloperidol has a half-life of 14 to 
26 hours, whereas ketamine has a half-life of 15 
minutes for its alpha phase and 2.5 hours for its beta 
phase.21,13 Therefore, multiple doses or infusions of 
haloperidol would ordinarily not be necessary for 
the treatment of ketamine-induced ED. Normally, a 
single dose should suffice.22
Haloperidol is associated with cardiac 
dysrythmias and extrapyramidal side effects such 
as dystonia, tardative dyskinesia, akathisia, and 
neuroleptic malignant syndrome.23,24 However, 
these side effects occur infrequently, this is 
particularly notable given the relatively low dose 
of haloperidol which appears necessary for the 
treatment of ketamine-induced ED.22,25
To the best of the authors’ knowledge, no 
similar studies have been conducted in children 
who received haloperidol for the sake of preventing 
consequent postoperative ED. Furthermore, most of 
the studies were carried out in developed countries. 
This work aimed to evaluate the effectiveness 
of haloperidol prophylaxis on postoperative 
ketamine -induced delirium in children. The authors 
hypothesised that preoperative administration of 
haloperidol would greatly decrease the incidence of 
postoperative ED.
Methods
The subjects for this clinical prospective 
randomised study were 537 consecutive children 
undergoing minor surgery at the Mansoura 
University Hospital in Mansoura City, Egypt, 
between June 2010 and May 2011. Eligibility 
criteria included children aged 6–16 years 
undergoing removal of stitches, laceration repair, 
removal of foreign bodies, abscess incision and 
drainage, and any examination for which general 
anaesthesia was required. Inclusion criteria 
included those classified under the American 
Society of Anaesthesiologists’ (ASA) designations 
of class I or II. Exclusion criteria included children 
allergic to ketamine, those with porphyria or active 
respiratory tract infections, and those undergoing 
surgery of the oropharynx. Patients with hepatic 
or renal impairment or a previous history of 
psychiatric illness, or those taking antidepressants, 
benzodiazepines, or antipsychotics were also 
excluded.
Does Haloperidol Prophylaxis Reduce Ketamine-Induced Emergence Delirium in Children?
258 | SQU Medical Journal, May 2013, Volume 13, Issue 2
Written informed consent was signed by a 
parent of each patient. For all patients, tests of 
preoperative liver or renal function, evaluations of 
the patient’s complete blood count and coagulation 
profile, and tests for levels of blood sugar and 
serum electrolytes were done. A systematic sample 
was taken (a sample design in which a list of the 
population is used as a sampling frame and cases 
are selected by skipping through the list at regular 
intervals) and the patients were classified into two 
groups. One hour before the start of anaesthesia, 
patients in Group I (haloperidol group, n = 267) 
were given a haloperidol 0.025 mg/Kg in 5 ml of 
distilled water IV while patients in Group II (placebo 
group, n = 270) were given a 5 ml distilled water 
IV. All equipment for intubation and ventilation 
was kept on standby. Anaesthesia was induced 
by ketamine 0.5–1 mg/Kg IV and increments as 
needed to facilitate surgery. The ASA standard of 
monitoring was carried out in the form of peripheral 
oxygen saturation, indirect blood pressure, and an 
electrocardiogram (ECG) and pulse rate were taken 
at intervals of 5 minutes during the procedure 
and 10 minutes during recovery. At the end of 
the surgery, the patients were moved to the post-
anaesthesia care unit (PACU) which was under the 
supervision of an anaesthesiologist. For all patients, 
pain was assessed and treated so as to obtain a pain 
level <4 on the 0–10 visual analogue scale (VAS).26 
Paracetamol (Perfalgan®) was given at a dose of 15 
mg/Kg every 4–6 hours as a slow IV infusion over 
15 minutes, for pain registering at a VAS score of 
above 3.
At the PACU, which was also staffed by a well-
qualified nurses, the parents were guided to give 
their children psychological support, and there was 
no need to dim the lights or eliminate auditory and 
visual stimuli. As recommended by Cole et al., a 
prospective observation of the children’s behaviour 
was made in the recovery room 30 minutes after 
the patient’s arrival in the PACU.27 The children 
were eventually discharged under the supervision 
of the family and the treating physician. A follow-
up telephone call was carried out by the research 
assistant and or the authors at the end of the first 
postoperative month.
Data were analysed using the Statistical Package 
for Social Sciences (SPSS), Version 11 (IBM, Inc., 
Chicago, Illinois, USA). Quantitative variables 
were tested for normality distribution by the 
Kolmogorov-Smirnov test. Quantitative variables 
were displayed as mean ± standard deviation (SD). 
Qualitative variables were presented as numbers and 
percentages. The differences between the means of 
the two groups were assessed using an independent 
t-test. The chi-square test was used for comparison 
of count and percentage of the two groups. A value 
of P ≤0.05 was considered statistically significant.
Results 
A total of 537 children (386 males, 151 females) at 
Mansoura University Hospital were anaesthetised 
in 2010–2011 for minor surgery. The mean ages 
for the first group and second group were 10.69 ± 
2.3 years and 10.98 ± 2.8 years, respectively. The 
mean anaesthesia time for the first and second 
groups was 23.8 ± 5.6 minutes and 24.4 ± 4.7 
minutes, respectively. The mean surgery times for 
the first and second groups were 17.9 ± 3.9 minutes 
and 18.4 ± 3.5 minutes, respectively. The patients’ 
demographic features are shown in Table 1. 
Insignificant haemodynamic changes were 
observed preoperatively, every five minutes 
intraoperatively and postoperatively between the 
two groups for both indirect blood pressure and 
heart rate [Figures 1 and 2].
There were significant PACU behavioural 
differences between the two groups. The ketamine-
haloperidol group yielded more sleepy, calm 
patients. In contrast, the ketamine group showed 
more irritability, inconsolable crying, and 
disorientation [Table 2]. There was a significant 
difference in VAS. The mean was 3.8 for the ketamine 
group and 2.1 for the ketamine-haloperidol group 
(P <0.001). The mean PACU stay duration for the 
ketamine group was 143.6 ± 12.9 minutes. For the 
Table 1: Pertinent characteristics of the study subjects
Ketamine 
(n = 270)
Ketamine 
and 
haloperidol 
(n = 267)
P value
Age 10.69 ± 2.3 10.98 ± 2.8 0.19
Weight 34.9 ± 11.3 36.2 ± 9.4 0.148
Anaesthesia 
time
23.8 ± 5.6 24.4 ± 4.7 0.1795
Surgical time 
(minutes)
17.9 ± 3.9 18.4 ± 3.5 0.1186
Sex (M/F) 202/68 184/83 0.128
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ketamine-halperidol group it was 56.4 ± 8.7 minutes 
(P = 0.000).
A telephone follow-up was attempted in all 
cases, and was successful in 434 patients (80.8%).
In the haloperidol group, three patients (1.1%) 
experienced extrapyramidal side effects in the 
form of a dystonic reaction. In the ketamine 
group,11 4.07% of patients reported nightmares. 
Two could not see properly and one complained of 
the room spinning in the postoperative weeks. In 
the ketamine-haloperidol group, only two (0.75%) 
patients reported difficulties—one of them reported 
crying and another reported having nightmares (P 
0.0126).
Discussion
Kalisvaart et al. reported that haloperidol 
prophylaxis significantly reduced the severity 
and duration of delirium and facilitated a rapid 
discharge from hospital.28 In a retrospective cohort 
study, Milbrandt et al.29 reported that haloperidol 
use was associated with a decreased mortality 
rate in mechanically ventilated patients.30 As a 
result, the burden of postoperative delirium on the 
patients and caregivers was less, as was the number 
of days patients stayed in the intensive care unit 
(ICU). In this study, we found that preoperative 
administration of haloperidol decreased the 
incidence of postoperative delirium from 6.3% to 
1.9% in a sample of children undergoing minor 
surgery in Mansoura, Egypt, which is congruent 
with earlier work conducted in elderly adults.11 
Moreover, haloperidol prophylaxis was found to 
be better than other medications used in previous 
paediatric practice. Midazolam is often combined 
with small doses of ketamine for sedation 
during local anaesthesia because it attenuates 
the cardiostimulatory response of ketamine 
and prevents unpleasant emergence reactions.31 
Unfortunately, when small doses of ketamine are 
administered in combination with midazolam, 
patients may still become confused, disoriented, 
and experience vivid dreaming or blurred vision 
during the operation.32,33
Table 2: Observations of child behaviour in the 
recovery room.
Feature Ketamine 
(n = 270) 
n (%)
Ketamine 
and 
haloperidol 
(n = 267) n 
(%) 
P
Sleeping 175 (64.8) 234 (87.6) 0.004**
Awake, calm 41 (15.2) 17 (6.4) 0.002**
Irritable, crying 21 (7.8) 6 (2.2) 0.004**
Inconsolable 
crying
16 (5.9) 5 (1.9) 0.016*
(Severe 
restlessness) 
disorientation
17 (6.3) 5 (1.9) 0.01**
P = P value; * = significant (P ≤0.05); ** = highly significant (P ≤0.01).
Figure 1: Mean blood pressure in the studied groups.
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Extrapyramidal symptoms, hypotension, altered 
cardiac conduction, and sedation are side effects 
associated with haloperidol and are dose-dependent; 
hence, it is advised that low doses of haloperidol are 
given for short periods of time, especially for elderly 
patients. In our study, it was administered IV by a 
bolus injection (0.5 mg), followed by a continuous 
infusion (at a rate of 0.1 mg/hour) for 12 hours. 
The aim of the bolus injection was to facilitate the 
patient reaching a therapeutic blood level rapidly 
once the drug was started. The bolus dose was 
chosen according to the suggested starting dose for 
the treatment of delirium in elderly patients.34 In 
critical children, haloperidol has to be given by IV, 
but continuous IV is associated with a more stable 
plasma level.35,36 In contrast to other studies, we 
used prophylactic haloperidol for a much shorter 
period of time in order to limit the ICU stay (143.6 
± 12.9 minutes; for the ketamine-haloperidol group 
the stay was 56.4 ± 8.7 minutes) and it decreased 
the incidence, course, and complications of early 
postoperative delirium.28,35
In our study, the use of haloperidol had a 
positive effect in reducing the duration of the 
PACU stay (143.6 ± 12.9 minutes for the ketamine 
group and 56.4 ± 8.7 minutes for the ketamine-
haloperidol group). Honkaniemi et al. reported 
that the use of 5 mg of haloperidol in patients 
with migraines decreased VAS values. The current 
study also showed that the VAS was less in the 
ketamine-haloperidol group as compared to the 
ketamine group, as evidenced by more patients 
being able to remain sleepy and calm.37 Generally, 
low doses of haloperidol have been adequate in 
eliminating, or significantly reducing, the ED 
associated with ketamine. It is our recommendation 
that practitioners using ketamine have haloperidol 
readily available. 
There are three limitations to the study. First, our 
study was conducted only in one faculty hospital; 
thus, we are not able to generalise our findings to 
all of Egypt. Secondly, only children undergoing 
minor surgery were recruited. Thirdly, risk factors 
that could possible modify our results, such as the 
temperaments of the children, were not assessed.
Conclusion
The administration of haloperidol greatly decreased 
the incidence of postoperative ED in a sample of 
children undergoing minor surgery. This work 
provides great hope of decreasing and even 
preventing delirium in hospitalised, nonsurgical 
patients. Limited resources and lack of well qualified 
nursing staff magnify the benefit of pharmacological 
approaches to delirium prevention in developing 
countries. It is our recommendation that 
haloperidol should be available for those children 
who are delirious from the use of ketamine.
Figure 2: Heart rate in the studied groups.
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